A new case study published in Cureus by Saami Khalifian, MD; Alec D. McCarthy, MD; and Steven Yoelin, MD, examines the efficacy and safety of an injectable therapy for treating neck wrinkles and skin laxity. This therapy combines hyperdiluted calcium hydroxylapatite (CaHA), platelet-rich plasma (PRP), and hyaluronidase.
Two patients with moderate neck wrinkles and skin laxity received the treatment and were evaluated several months later.
The study found that a single treatment with the combined therapy improved skin texture and laxity.
The inclusion of PRP and hyaluronidase aimed to enhance the regenerative effects of CaHA. PRP is rich in growth factors that stimulate collagen production and regeneration, while hyaluronidase breaks down hyaluronic acid, promoting better diffusion and even product dispersion.
The findings from these cases provide preliminary evidence supporting the safety and efficacy of this innovative combination therapy for addressing neck wrinkles and laxity.
According to the researchers, this is the first documented instance of using CaHA in conjunction with hyaluronidase and PRP for skin priming.
Further investigations are needed to explore the application of this treatment for other anatomical regions and to clarify the role of each injected component.
Read complete findings at Cureus
More from The Blog
Best Neuromodulator ROI 2025: Cost Comparison Botox, Daxxify, Juveau, Dysport, Xeomin & Letybo
Best Neuromodulator 2025: Compare Botox, Daxxify, Juveau, Xeomin & Letybo Medical Spa injectors all have their favorites, but if you are new to the industry or are considering adding Letybo to your neuromodulator offerings, then understanding the ROI associated...
Industry Update: Alpha Aesthetics Partners Expands Network with Mint & Needle Acquisition
Alpha Aesthetics Partners has announced its newest partnership with Mint & Needle, a Delaware-based aesthetics practice that has been making waves since its founding in 2019. This acquisition marks another strategic expansion for Alpha Aesthetics Partners, which...
XWELL Expands into the Medspa Sector: What It Means for the Industry
XWELL, a company traditionally focused on wellness services, has announced its expansion into the medical spa sector with plans to acquire multiple medspa locations by the end of 2025. This move aligns with the industry’s growing trend of strategic mergers and...
Federal Judge Halts Compounded Copies of Eli Lilly’s Weight Loss Drugs
Date: March 6, 2025Source: The Hill In a game-changing ruling, a federal judge in Texas has stopped compounding pharmacies from making affordable versions of Eli Lilly’s blockbuster weight loss drugs, Zepbound and Mounjaro. On March 5, 2025, Judge Mark Pittman upheld...
